Oxford Lane Capital Corp 625 Series 2027 Term Preferred Shares OXLCP Q4 2025 Earnings EPS Misses Estimates as Preferred Shares Edge Slightly Higher Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations LUCY Q1 2026 Earnings EPS Surprises with a 2282 Beat Despite Missing Revenue Details ERO Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Higher Copper Prices XGN Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Revenue Uncertainty SCM Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Declines